“…In another context ( Advani et al, 2023 ), aimed at replicating the most common genetic associations of chemotherapy-related cardiotoxicity in the adjuvant NSABP B-31 clinical trial. Using genotyping data from 993 patients, TRPC6 rs77679196 and CBR3 rs1056892 (V244M) were found to be linked to doxorubicin-induced cardiac events in both NCCTG N9831 and NSABP B-31.…”